tradingkey.logo
tradingkey.logo

Quantum Biopharma Announces Positive Results Of The Clinical Study Report (CSR)

ReutersAug 5, 2025 12:37 PM

- Quantum Biopharma Ltd QNTM.CD:

  • QUANTUM BIOPHARMA ANNOUNCES POSITIVE RESULTS OF THE CLINICAL STUDY REPORT (CSR) FOR THE PHASE 1 MULTIPLE ASCENDING DOSE (MAD) CLINICAL TRIAL OF EXPERIMENTAL MULTIPLE SCLEROSIS DRUG LUCID-21-302 (LUCID-MS)

  • QUANTUM BIOPHARMA LTD - CSR FINDS NO SAFETY CONCERNS FOR LUCID-MS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI